v3.26.1
Equity - Statement of Stockholders' Equity (Details) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Increase (Decrease) in Stockholders' Equity    
Balance at the beginning of the period $ 885,509 $ 770,770
Net income (loss) (324) 11,947
Other comprehensive income (loss), net of tax (472) 108
Share-based compensation expense 8,511 9,208
Settlement of convertible notes   26,500
Net issuance under employee stock plans (9,562) (6,675)
Balance at the end of the period 883,662 811,858
Common Stock    
Increase (Decrease) in Stockholders' Equity    
Balance at the beginning of the period $ 604 $ 569
Balance at the beginning of the period (in shares) 60,389 56,828
Settlement of convertible notes   $ 11
Settlement of convertible notes (in shares)   1,104
Net issuance under employee stock plans $ 6 $ 3
Net issuance under employee stock plans (in shares) 643 360
Balance at the end of the period $ 610 $ 583
Balance at the end of the period (in shares) 61,032 58,292
Additional Paid-in Capital    
Increase (Decrease) in Stockholders' Equity    
Balance at the beginning of the period $ 1,306,176 $ 1,227,134
Share-based compensation expense 8,511 9,208
Settlement of convertible notes   26,489
Net issuance under employee stock plans (9,568) (6,678)
Balance at the end of the period 1,305,119 1,256,153
Accumulated Deficit    
Increase (Decrease) in Stockholders' Equity    
Balance at the beginning of the period (423,065) (458,455)
Net income (loss) (324) 11,947
Balance at the end of the period (423,389) (446,508)
Accumulated Other Comprehensive Income    
Increase (Decrease) in Stockholders' Equity    
Balance at the beginning of the period 1,794 1,522
Other comprehensive income (loss), net of tax (472) 108
Balance at the end of the period $ 1,322 $ 1,630